# Bioequivalence of a Test Troche Formulation of Fentanyl Citrate (400 mcg) Compared to Actiq® 400 mcg, Cephalon, Inc.

> **NCT01173627** · PHASE1 · COMPLETED · sponsor: **Mallinckrodt** · enrollment: 50 (actual)

## Conditions studied

- Pain

## Interventions

- **DRUG:** Test fentanyl citrate 400 mcg troche
- **DRUG:** Actiq 400 mcg

## Key facts

- **NCT ID:** NCT01173627
- **Lead sponsor:** Mallinckrodt
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-08
- **Primary completion:** 2006-08
- **Final completion:** 2006-08
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2016-10-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01173627

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01173627, "Bioequivalence of a Test Troche Formulation of Fentanyl Citrate (400 mcg) Compared to Actiq® 400 mcg, Cephalon, Inc.". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT01173627. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*